103 related articles for article (PubMed ID: 2543485)
1. [HIV envelope proteins are bound by human epidermal Langerhans cells by a binding site which differs from the site on the CD4 molecule, and are internalized by receptor endocytosis].
Schmitt D; Dezutter-Dambuyant C; Hanau D; Schmitt DA; Kolbe HV; Kieny MP; Cazenave JP; Thivolet J
C R Acad Sci III; 1989; 308(10):269-75. PubMed ID: 2543485
[TBL] [Abstract][Full Text] [Related]
2. In vitro binding and internalization of HIV envelope glycoproteins by human epidermal Langerhans cells does not require the CD4-gp120-binding site.
Schmitt D; Dezutter-Dambuyant C; Hanau D; Kolbe HV; Kieny MP; Cazenave JP; Thivolet J
Res Virol; 1990; 141(2):209-15. PubMed ID: 1693220
[TBL] [Abstract][Full Text] [Related]
3. Interaction of human epidermal Langerhans cells with HIV-1 viral envelope proteins (gp 120 and gp 160s) involves a receptor-mediated endocytosis independent of the CD4 T4A epitope.
Dezutter-Dambuyant C; Schmitt DA; Dusserre N; Hanau D; Kolbe HV; Kieny MP; Cazenave JP; Schmitt D; Pasquali JL; Olivier R
J Dermatol; 1991 Jul; 18(7):377-92. PubMed ID: 1724250
[TBL] [Abstract][Full Text] [Related]
4. Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.
McDougal JS; Nicholson JK; Cross GD; Cort SP; Kennedy MS; Mawle AC
J Immunol; 1986 Nov; 137(9):2937-44. PubMed ID: 2428879
[TBL] [Abstract][Full Text] [Related]
5. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.
Mann DL; Read-Connole E; Arthur LO; Robey WG; Wernet P; Schneider EM; Blattner WA; Popovic M
J Immunol; 1988 Aug; 141(4):1131-6. PubMed ID: 2840463
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD4 molecules neutralize human immunodeficiency virus type 1.
Traunecker A; Lüke W; Karjalainen K
Nature; 1988 Jan; 331(6151):84-6. PubMed ID: 2829024
[TBL] [Abstract][Full Text] [Related]
7. Receptor molecule blocks HIV.
Weiss RA
Nature; 1988 Jan; 331(6151):15. PubMed ID: 2829021
[No Abstract] [Full Text] [Related]
8. HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis.
Mann DL; Lasane F; Popovic M; Arthur LO; Robey WG; Blattner WA; Newman MJ
J Immunol; 1987 Apr; 138(8):2640-4. PubMed ID: 3031162
[TBL] [Abstract][Full Text] [Related]
9. A soluble form of CD4 (T4) protein inhibits AIDS virus infection.
Deen KC; McDougal JS; Inacker R; Folena-Wasserman G; Arthos J; Rosenberg J; Maddon PJ; Axel R; Sweet RW
Nature; 1988 Jan; 331(6151):82-4. PubMed ID: 3257544
[TBL] [Abstract][Full Text] [Related]
10. Characterization of CD4 glycoprotein determinant-HIV envelope protein interactions: perspectives for analog and vaccine development.
Farrar WL; Harel-Bellan A; Ferris DK
Crit Rev Immunol; 1988; 8(4):315-39. PubMed ID: 2850890
[TBL] [Abstract][Full Text] [Related]
11. HIV infection is blocked in vitro by recombinant soluble CD4.
Fisher RA; Bertonis JM; Meier W; Johnson VA; Costopoulos DS; Liu T; Tizard R; Walker BD; Hirsch MS; Schooley RT
Nature; 1988 Jan; 331(6151):76-8. PubMed ID: 2829022
[TBL] [Abstract][Full Text] [Related]
12. Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.
Fenouillet E; Clerget-Raslain B; Gluckman JC; Guétard D; Montagnier L; Bahraoui E
J Exp Med; 1989 Mar; 169(3):807-22. PubMed ID: 2538547
[TBL] [Abstract][Full Text] [Related]
13. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.
Hussey RE; Richardson NE; Kowalski M; Brown NR; Chang HC; Siliciano RF; Dorfman T; Walker B; Sodroski J; Reinherz EL
Nature; 1988 Jan; 331(6151):78-81. PubMed ID: 2829023
[TBL] [Abstract][Full Text] [Related]
14. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4.
Landau NR; Warton M; Littman DR
Nature; 1988 Jul; 334(6178):159-62. PubMed ID: 3260352
[TBL] [Abstract][Full Text] [Related]
15. Identification of nanopeptide from HTLV-III, ARV-2 and LAVBRU envelope gp120 determining binding to T4 cell surface protein.
Veljković V; Metlas R
Cancer Biochem Biophys; 1988 Nov; 10(2):91-106. PubMed ID: 2855309
[TBL] [Abstract][Full Text] [Related]
16. Structural features of CD4 required for binding to HIV.
Ibegbu CC; Kennedy MS; Maddon PJ; Deen KC; Hicks D; Sweet RW; McDougal JS
J Immunol; 1989 Apr; 142(7):2250-6. PubMed ID: 2538505
[TBL] [Abstract][Full Text] [Related]
17. Characterization of GP120 binding to CD4 and an assay that measures ability of sera to inhibit this binding.
Schnittman SM; Lane HC; Roth J; Burrows A; Folks TM; Kehrl JH; Koenig S; Berman P; Fauci AS
J Immunol; 1988 Dec; 141(12):4181-6. PubMed ID: 3264307
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte activation by HIV-1 envelope glycoprotein.
Kornfeld H; Cruikshank WW; Pyle SW; Berman JS; Center DM
Nature; 1988 Sep; 335(6189):445-8. PubMed ID: 2843775
[TBL] [Abstract][Full Text] [Related]
19. Diversity of receptors binding HIV on dendritic cell subsets.
Turville SG; Cameron PU; Handley A; Lin G; Pöhlmann S; Doms RW; Cunningham AL
Nat Immunol; 2002 Oct; 3(10):975-83. PubMed ID: 12352970
[TBL] [Abstract][Full Text] [Related]
20. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.
Clayton LK; Sieh M; Pious DA; Reinherz EL
Nature; 1989 Jun; 339(6225):548-51. PubMed ID: 2543930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
